clinical trial · NCT07544628
A Phase 1 Study of Navlimetostat Tablet Formulations
Bristol-Myers Squibb·phase1·not yet recruiting·n = 64
Healthy ParticipantsNavlimetostat
brief summary
This study aims to compare the PK of Navlimetostat after administration of a wet-granulation tablet versus the dry-granulation tablet formulation in healthy adult female
started
Apr 30, 2026
primary completion
Aug 31, 2026
completion
Oct 15, 2026
last updated
Apr 22, 2026
official title
A Phase 1, Open-label, Randomized, 2-Treatment, 2-Period, Crossover Study to Assess the Bioequivalence of Navlimetostat Wet-Granulation Tablet Versus the Dry-Granulation Tablet Formulation in Healthy Adult Female (as Assigned at Birth) Participants Who Are Individuals Not of Childbearing Potential
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol